Tech Company Financing Transactions
AbVitro Funding Round
AbVitro, based in Boston, secured $1.1 million in funding from Sante Ventures.
Transaction Overview
Company Name
Announced On
6/30/2013
Transaction Type
Venture Equity
Amount
$1,129,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
27 Drydock Ave 6th Floor
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Overview
AbVitro is a venture backed next-generation antibody discovery focused on discovery of human-derived antibodies and biomarkers that are otherwise intractable using existing approaches.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Ostrove
Chief Scientific Officer
Francois Vigneault
Browse more venture capital transactions:
Prev: 6/30/2013: Faraday Bicycles venture capital transaction
Next: 6/30/2013: Collections Marketing Center venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs